Charles Schwab
GMAB icon

Charles Schwab’s Genmab GMAB Stock Holding History

Charles Schwab’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.82M Buy
139,125
+11,554
+9% +$307K ﹤0.01% 2576
2026
Q1 		$3.42M Buy
127,571
+16,772
+15% +$503K ﹤0.01% 2557
2025
Q4 		$3.41M Buy
110,799
+9,620
+10% +$300K ﹤0.01% 2595
2025
Q3 		$3.1M Buy
101,179
+24,688
+32% +$602K ﹤0.01% 2634
2025
Q2 		$1.58M Buy
76,491
+28,617
+60% +$587K ﹤0.01% 2746
2025
Q1 		$937K Sell
47,874
-13,303
-22% -$279K ﹤0.01% 2861
2024
Q4 		$1.28M Buy
61,177
+35,073
+134% +$771K ﹤0.01% 2826
2024
Q3 		$636K Buy
26,104
+12,654
+94% +$338K ﹤0.01% 3072
2024
Q2 		$338K Sell
13,450
-13,830
-51% -$392K ﹤0.01% 3335
2024
Q1 		$816K Buy
27,280
+10,055
+58% +$295K ﹤0.01% 2854
2023
Q4 		$548K Sell
17,225
-1,115
-6% -$35K ﹤0.01% 3044
2023
Q3 		$647K Buy
18,340
+10,891
+146% +$415K ﹤0.01% 2949
2023
Q2 		$283K Buy
+7,449
New +$297K ﹤0.01% 3246

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Charles Schwab's GMAB Position: Q2 2026 in Review

Charles Schwab increased its Genmab (GMAB) stake by 9.1% in Q2 2026, buying an estimated $307K and bringing the position to 139,125 shares worth $3.82M. The position accounts for ﹤0.01% of the portfolio, ranked #2576.

Charles Schwab first reported a position in GMAB in Q2 2023 and has held it in 13 quarters since. 289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Charles Schwab held 139,125 shares of Genmab worth $3.82M as of Q2 2026.
  • Charles Schwab bought 11,554 Genmab shares in Q2 2026, an estimated $307K.
  • Genmab made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #2576 holding.
  • Charles Schwab first reported a position in Genmab in Q2 2023 and has held it in 13 quarters since.
  • 289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.